HCB101, a novel Fc-based anti-SIRPα-CD47 fusion protein, has received orphan drug designation (ODD) from the FDA for the ...
As theranostic radiopharmaceuticals gain prevalence, companies must overcome associated regulatory, manufacturing and ...
For many cancer patients, hair loss is one of the most distressing side effects of their therapy. Increasingly, they have been taking oral supplements of biotin, which are marketed to consumers for ...
A cohort study examines whether the use of common medications was associated with worse outcomes in patients with lung cancer taking immunotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results